To evaluate whether BCL-XL overexpression promotes tumor progression-associated properties, we used control and BCL-XL overexpressing clones generated from human melanoma M14 (Mneo, MXL90) and ADF glioblastoma (AN8, AXL74) cells13 (Fig. 1a). The gene discussed is BCL2L1; the disease is glioblastoma.